Horvath KV - Search Results

1

Niisuke K, Horvath KV, Asztalos BF. Niisuke K, et al. Among authors: horvath kv. Curr Opin Lipidol. 2018 Aug;29(4):293-298. doi: 10.1097/MOL.0000000000000529. Curr Opin Lipidol. 2018. PMID: 29846266 Review.

2

Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients.

Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ. Asztalos BF, et al. Among authors: horvath kv. Atherosclerosis. 2002 Oct;164(2):361-9. doi: 10.1016/s0021-9150(02)00149-1. Atherosclerosis. 2002. PMID: 12204809 Clinical Trial.

3

Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients.

Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ. Asztalos BF, et al. Among authors: horvath kv. J Lipid Res. 2002 Oct;43(10):1701-7. doi: 10.1194/jlr.m200037-jlr200. J Lipid Res. 2002. PMID: 12364554 Free article. Clinical Trial.

4

Change in alpha1 HDL concentration predicts progression in coronary artery stenosis.

Asztalos BF, Batista M, Horvath KV, Cox CE, Dallal GE, Morse JS, Brown GB, Schaefer EJ. Asztalos BF, et al. Among authors: horvath kv. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):847-52. doi: 10.1161/01.ATV.0000066133.32063.BB. Epub 2003 Mar 13. Arterioscler Thromb Vasc Biol. 2003. PMID: 12637338 Clinical Trial.

5

Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins.

Lamon-Fava S, Posfai B, Asztalos BF, Horvath KV, Dallal GE, Schaefer EJ. Lamon-Fava S, et al. Among authors: horvath kv. Metabolism. 2003 Oct;52(10):1330-6. doi: 10.1016/s0026-0495(03)00276-2. Metabolism. 2003. PMID: 14564686 Clinical Trial.

6

Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency.

Asztalos BF, Horvath KV, Kajinami K, Nartsupha C, Cox CE, Batista M, Schaefer EJ, Inazu A, Mabuchi H. Asztalos BF, et al. Among authors: horvath kv. J Lipid Res. 2004 Mar;45(3):448-55. doi: 10.1194/jlr.M300198-JLR200. Epub 2003 Dec 1. J Lipid Res. 2004. PMID: 14657195 Free article.

7

High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.

Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ. Asztalos BF, et al. Among authors: horvath kv. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2181-7. doi: 10.1161/01.ATV.0000146325.93749.a8. Epub 2004 Sep 23. Arterioscler Thromb Vasc Biol. 2004. PMID: 15388521

8

Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients.

Asztalos BF, Schaefer EJ, Horvath KV, Cox CE, Skinner S, Gerrior J, Gorbach SL, Wanke C. Asztalos BF, et al. Among authors: horvath kv. Atherosclerosis. 2006 Jan;184(1):72-7. doi: 10.1016/j.atherosclerosis.2005.04.013. Epub 2005 Jun 1. Atherosclerosis. 2006. PMID: 15935358

9

Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux.

Asztalos BF, de la Llera-Moya M, Dallal GE, Horvath KV, Schaefer EJ, Rothblat GH. Asztalos BF, et al. Among authors: horvath kv. J Lipid Res. 2005 Oct;46(10):2246-53. doi: 10.1194/jlr.M500187-JLR200. Epub 2005 Aug 1. J Lipid Res. 2005. PMID: 16061948 Free article.

10

Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.

Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ. Asztalos BF, et al. Among authors: horvath kv. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2185-91. doi: 10.1161/01.ATV.0000183727.90611.4f. Epub 2005 Aug 25. Arterioscler Thromb Vasc Biol. 2005. PMID: 16123324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page